Ronald G. Coffey

3.0k total citations
70 papers, 2.3k citations indexed

About

Ronald G. Coffey is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Ronald G. Coffey has authored 70 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 19 papers in Physiology and 17 papers in Immunology. Recurrent topics in Ronald G. Coffey's work include Asthma and respiratory diseases (14 papers), Carbohydrate Chemistry and Synthesis (8 papers) and Adenosine and Purinergic Signaling (8 papers). Ronald G. Coffey is often cited by papers focused on Asthma and respiratory diseases (14 papers), Carbohydrate Chemistry and Synthesis (8 papers) and Adenosine and Purinergic Signaling (8 papers). Ronald G. Coffey collaborates with scholars based in United States, France and Italy. Ronald G. Coffey's co-authors include John W. Hadden, David F. Fitzpatrick, Elba M. Hadden, Elliott Middleton, F.J. Reithel, Geoffrey H. Sunshine, Andrew Eisen, Paul Jantzen, John S. Davis and Elizabeth Snella and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ronald G. Coffey

70 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronald G. Coffey United States 27 737 507 470 264 255 70 2.3k
Ivana Serraino Italy 28 658 0.9× 394 0.8× 326 0.7× 401 1.5× 231 0.9× 37 2.3k
Michael P. Neeper United States 20 922 1.3× 426 0.8× 518 1.1× 265 1.0× 49 0.2× 26 3.3k
Elisabeth Teissier France 27 1.5k 2.0× 434 0.9× 599 1.3× 265 1.0× 285 1.1× 43 3.1k
Shuichi Kimura Japan 26 654 0.9× 470 0.9× 121 0.3× 244 0.9× 148 0.6× 158 2.4k
Satoshi Yamamoto Japan 26 950 1.3× 248 0.5× 221 0.5× 193 0.7× 115 0.5× 69 1.9k
Stanislava Stošić‐Grujičić Serbia 30 734 1.0× 239 0.5× 1.1k 2.3× 272 1.0× 211 0.8× 98 2.8k
K Iwata Japan 28 831 1.1× 680 1.3× 576 1.2× 130 0.5× 48 0.2× 112 2.8k
Santosh Nigam Germany 32 1.3k 1.7× 366 0.7× 305 0.6× 839 3.2× 79 0.3× 122 3.1k
D. S. Robinson United Kingdom 31 584 0.8× 1.1k 2.2× 356 0.8× 259 1.0× 50 0.2× 61 3.1k
Ettore Bergamini Italy 23 1.8k 2.5× 918 1.8× 236 0.5× 279 1.1× 116 0.5× 76 4.3k

Countries citing papers authored by Ronald G. Coffey

Since Specialization
Citations

This map shows the geographic impact of Ronald G. Coffey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald G. Coffey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald G. Coffey more than expected).

Fields of papers citing papers by Ronald G. Coffey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald G. Coffey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald G. Coffey. The network helps show where Ronald G. Coffey may publish in the future.

Co-authorship network of co-authors of Ronald G. Coffey

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald G. Coffey. A scholar is included among the top collaborators of Ronald G. Coffey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald G. Coffey. Ronald G. Coffey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coffey, Ronald G., Yoshimasa Yamamoto, Elizabeth Snella, & Susan Pross. (1996). Tetrahydrocannabinol inhibition of macrophage nitric oxide production. Biochemical Pharmacology. 52(5). 743–751. 65 indexed citations
2.
Hadden, Elba M., et al.. (1995). Methyl inosine monophosphate (MIMP) augments T-lymphocyte mitogen responses and reverses various immunosuppressants. International Journal of Immunopharmacology. 17(9). 763–770. 4 indexed citations
3.
Fitzpatrick, David F., et al.. (1995). Endothelium-Dependent Vasorelaxation Caused by Various Plant Extracts. Journal of Cardiovascular Pharmacology. 26(1). 90–95. 137 indexed citations
4.
Coffey, Ronald G., et al.. (1993). Suppression of lymphocyte adenosine 3′ : 5′-cyclic monophosphate (cAMP) by delta-9-tetrahydrocannabinol. International Journal of Immunopharmacology. 15(4). 523–532. 16 indexed citations
5.
6.
Coffey, Ronald G.. (1992). Granulocyte responses to cytokines. Basic and clinical research.. PubMed. 57. 1–693. 33 indexed citations
7.
Coffey, Ronald G.. (1992). Effects of cyclic nucleotides on granulocytes.. PubMed. 57. 301–38. 24 indexed citations
8.
Davis, John S., Laura L. Weakland, Ronald G. Coffey, & L A West. (1989). Acute effects of phorbol esters on receptor-mediated IP3, cAMP, and progesterone levels in rat granulosa cells. American Journal of Physiology-Endocrinology and Metabolism. 256(3). E368–E374. 13 indexed citations
9.
Coffey, Ronald G., John S. Davis, & J Y Djeu. (1988). Stimulation of guanylate cyclase activity and reduction of adenylate cyclase activity by granulocyte-macrophage colony-stimulating factor in human blood neutrophils.. The Journal of Immunology. 140(8). 2695–2701. 57 indexed citations
10.
Sauro, Marie D., David F. Fitzpatrick, & Ronald G. Coffey. (1988). Defective cyclic GMP accumulation in spontaneously hypertensive rat aorta in response to atrial natriuretic factor. Biochemical Pharmacology. 37(11). 2109–2112. 8 indexed citations
11.
Hadden, John W., Elba M. Hadden, & Ronald G. Coffey. (1987). Interleukin II increases cyclic GMP levels in immature thymocytes and mitogen-primed T-lymphocytes. International Journal of Immunopharmacology. 9(7). 851–857. 7 indexed citations
12.
Coffey, Ronald G., et al.. (1984). Selective inhibition by NPT 15392 of lymphocyte cyclic GMP phosphodiesterase. Biochemical Pharmacology. 33(21). 3411–3417. 2 indexed citations
13.
Hadden, John W. & Ronald G. Coffey. (1980). Effects of BM 12,531 (Azimexon) on in Vitro Lymphocyte and Macrophage Proliferation. Recent results in cancer research. 75. 162–164. 3 indexed citations
14.
Hadden, John W., Ronald G. Coffey, Radha Ananthakrishnan, & Elba M. Hadden. (1979). CYCLIC NUCLEOTIDES AND CALCIUM IN LYMPHOCYTE REGULATION AND ACTIVATION*. Annals of the New York Academy of Sciences. 332(1). 241–254. 22 indexed citations
15.
Sunshine, Geoffrey H., et al.. (1978). Thymopoietin Enhances the Allogeneic Response and Cyclic GMP Levels of Mouse Peripheral, Thymus-Derived Lymphocytes. The Journal of Immunology. 120(5). 1594–1599. 73 indexed citations
16.
Coffey, Ronald G., Elba M. Hadden, & John W. Hadden. (1977). Evidence for Cyclic GMP and Calcium Mediation of Lymphocyte Activation by Mitogens. The Journal of Immunology. 119(4). 1387–1394. 69 indexed citations
17.
Coffey, Ronald G. & Elliott Middleton. (1975). Increased Adenosine Triphosphatase Activity in Platelets of Asthmatic Children. International Archives of Allergy and Immunology. 48(2). 171–181. 7 indexed citations
18.
Middleton, Elliott, et al.. (1972). Stimulation of leukocyte adenyl cyclase by hydrocortisone and isoproterenol in asthmatic and nonasthmatic subjects. Journal of Allergy and Clinical Immunology. 50(1). 45–56. 155 indexed citations
19.
Coffey, Ronald G. & F.J. Reithel. (1969). An enzymic determination of lactose. Analytical Biochemistry. 32(2). 229–232. 29 indexed citations
20.
Coffey, Ronald G., Vernon H. Cheldelin, & R.W. Newburgh. (1964). Glucose Utilization by Chick Embryo Heart Homogenates. The Journal of General Physiology. 48(1). 105–112. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivana Serraino Breakdown of academic impact, for papers by Michael P. Neeper Breakdown of academic impact, for papers by Elisabeth Teissier Breakdown of academic impact, for papers by Shuichi Kimura Breakdown of academic impact, for papers by Satoshi Yamamoto Breakdown of academic impact, for papers by Stanislava Stošić‐Grujičić Breakdown of academic impact, for papers by K Iwata Breakdown of academic impact, for papers by Santosh Nigam Breakdown of academic impact, for papers by D. S. Robinson Breakdown of academic impact, for papers by Ettore Bergamini
Rankless by CCL
2026